ASBP — Aspire Biopharma Holdings, Inc.

ASBPAspire Biopharma Holdings, Inc.

NAS · US · Healthcare · Biotechnology · aspirebiolabs.com

5.940USD+13.90%Mkt Cap: 7.68M USDP/E: —Last update: 2026-06-01

Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product th…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap7.68M USD

Enterprise Value2.75M USD

Revenue (TTM)34.55K USD

Gross Profit-116 USD

Net Income (TTM)-24.48M USD

Revenue/Share0.4260 USD

Last Price5.940 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees—

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue79.67

P/S205.78

P/B0.24

EPS (TTM)-7.09

EPS (Forward)—

52W Range

0.110017% of range35.00

52W High35.00 USD

52W Low0.1100 USD

Profitability

Gross Margin-1.87%

Oper. Margin-5805.98%

EBITDA Margin0.00%

Profit Margin-394725.06%

ROE383.93%

ROA-1865.68%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-4.92M USD

CapEx (TTM)—

FCF Margin63450.70%

FCF Yield285.45%

Net Debt-4.36M USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity-0.81

Current Ratio2.26

Quick Ratio1.86

Book Value/Sh23.10 USD

Cash/Share4.522 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:40

Split DateJan 16, 2026

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.1.30M

Float1.20M

Insiders0.96%

Institutions1.68%

Short Interest

Short Ratio0.1d

Short % Float5.91%

Short % Out.5.86%

Shares Short75.96K

Short (prev mo.)12.45K

Technical

SMA 501.905 (+211.9%)

SMA 2006.857 (-13.4%)

Beta—

S&P 52W Chg27.94%

Avg Vol (30d)25.77M

Avg Vol (10d)720.70K

Technical Indicators

RSI (14)62.9

MACD1.1401

MACD Signal1.1776

MACD Hist.-0.0375

BB Upper9.005 USD

BB Middle3.924 USD

BB Lower-1.1570 USD

BB Width258.97%

ATR (14)0.7798 USD

Vol Ratio (20d)0.01x